{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:40:20Z","timestamp":1791484820086,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","award":["TURSP\\u20102020\/52"],"award-info":[{"award-number":["TURSP\\u20102020\/52"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006261","name":"Taif University","doi-asserted-by":"publisher","award":["2020\/52"],"award-info":[{"award-number":["2020\/52"]}],"id":[{"id":"10.13039\/501100006261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bioorg.2021.105186","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T04:18:42Z","timestamp":1626927522000},"page":"105186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents"],"prefix":"10.1016","volume":"115","author":[{"given":"Nour E.A.","family":"Abd El-Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"El\u2010Adl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher A.","family":"El-Hashash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir A.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Elhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bioorg.2021.105186_b0005","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1007\/s00044-014-0959-3","article-title":"Design, synthesis, and biological study of 6,7-dihydro-5H-pyrano[2,3-d]pyrimidine derivatives as novel hedgehog signaling pathway inhibitors","volume":"23","author":"Xin","year":"2014","journal-title":"Med. Chem. Res."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105186_b0010","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1007\/s00044-012-0288-3","article-title":"Green approach towards the facile synthesis of dihydropyrano(c)chromene and pyrano[2,3-d]pyrimidine derivatives and their biological evaluation","volume":"22","author":"Paliwal","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105186_b0015","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s11164-015-2243-7","article-title":"Synthesis, antimicrobial activity and molecular docking studies of pyrano[2,3-d]pyrimidine formimidate derivatives","volume":"42","author":"Yalagala","year":"2016","journal-title":"Res. Chem. Intermed."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105186_b0020","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11172-008-0308-0","article-title":"Convenient selective synthesis of pyrano[2,3-d]pyrimidines","volume":"57","author":"Litvinov","year":"2008","journal-title":"Russ. Chem. Bull."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105186_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/13543780903505092","article-title":"Newer antibacterial drugs for a new century","volume":"19","author":"Devasahayam","year":"2010","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105186_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrmicro727","article-title":"Where will new antibiotics come from?","volume":"1","author":"Walsh","year":"2003","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105186_b0035","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00253-010-2877-8","article-title":"Sources of novel antibiotics\u2013aside the common roads","volume":"88","author":"Donadio","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105186_b0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ja.2010.62","article-title":"Antibiotic discovery in the twenty-first century: current trends and future perspectives","volume":"63","author":"Donadio","year":"2010","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.bioorg.2021.105186_b0045","series-title":"Enzybiotics: Antibiotic Enzymes as Drugs and Therapeutics","first-page":"1","author":"Villa","year":"2010"},{"key":"10.1016\/j.bioorg.2021.105186_b0050","author":"El-Adl","year":"2020","journal-title":"New J Chemistry"},{"key":"10.1016\/j.bioorg.2021.105186_b0055","doi-asserted-by":"crossref","unstructured":"Ibrahim. H. Eissa, Ahmed. M. Metwaly, Amany Belal, Ahmed. B. M. Mehany, Rezk R. Ayyad, Khaled El-Adl, Hazem. A. Mahdy, Mohammed. S. Taghour, Kamal M. A. El-Gamal, Mohamad E. El-Sawah, Souad A. Elmetwally, Mostafa. A. Elhendawy, Mohamed. M. Radwan, Mahmoud. A. ElSohly. Discovery and anti-proliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors. Archiv der Pharmazie, 2019;352:1900123. DOI:10.1002\/ardp.201900123.","DOI":"10.1002\/ardp.201900123"},{"key":"10.1016\/j.bioorg.2021.105186_b0060","doi-asserted-by":"crossref","unstructured":"Boda SK, Pishka V, Lakshmi PVA, Chinde S, Grover P. 1,2,3-Triazole Tagged 3H-Pyrano[2,3-d]pyrimidine-6-carboxylate Derivatives: Synthesis, in Vitro Cytotoxicity, Molecular Docking and DNA Interaction Studies. Chem Biodivers. 2018 Jun;15(6):e18000101. doi: 10.1002\/cbdv.201800101. Epub 2018 May 23. PMID: 29660245.","DOI":"10.1002\/cbdv.201800101"},{"issue":"89","key":"10.1016\/j.bioorg.2021.105186_b0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ejmech.2014.10.055","article-title":"Anthraquinone-chalcone hybrids: synthesis, preliminary antiproliferative evaluation and DNA-interaction studies","volume":"7","author":"Markovi\u0107","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105186_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115958","article-title":"[1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies","volume":"30","author":"El-Adl","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105186_b0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejmech.2011.09.040","article-title":"Efficient one-pot preparation of novel fused chromeno[2,3-d]pyrimidine and pyrano[2,3-d]pyrimidine derivatives","volume":"47","author":"Aly","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105186_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jare.2013.03.003","article-title":"Pentafluorophenylammonium triflate (PFPAT) catalyzed facile construction of substituted chromeno[2,3-d]pyrimidinone derivatives and their antimicrobial activity","volume":"5","author":"Ghashang","year":"2014","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2021.105186_b0085","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1007\/s11164-015-2243-7","article-title":"Synthesis, antimicrobial activity and molecular docking studies of pyrano[2,3-d]pyrimidine formimidate derivatives","volume":"42","author":"Yalagala","year":"2016","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.bioorg.2021.105186_b0090","doi-asserted-by":"crossref","first-page":"104480","DOI":"10.1016\/j.bioorg.2020.104480","article-title":"Synthesis, biological activity and POM\/DFT\/docking analyses of annulated pyrano[2,3-d]pyrimidine derivatives: Identification of antibacterial and antitumor pharmacophore sites","volume":"106","author":"Bhat","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2021.105186_b0095","doi-asserted-by":"crossref","unstructured":"J. L. Delgado, et al., Topoisomerases as anticancer targets. Biochem J. 475(2) 2018 373-398. doi: 10.1042\/BCJ20160583. PMID: 29363591; PMCID: PMC6110615.","DOI":"10.1042\/BCJ20160583"},{"key":"10.1016\/j.bioorg.2021.105186_b0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/0929867053363414","article-title":"The search of DNA-intercalators as antitumoral drugs: what it worked and what did not work","volume":"12","author":"Martinez","year":"2005","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105186_b0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev.bi.58.070189.002031","article-title":"DNA topoisomerase poisons as antitumor drugs","volume":"58","author":"Liu","year":"1989","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105186_b0110","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bmc.2008.11.072","article-title":"Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity","volume":"17","author":"Chilin","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105186_b0115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7326\/0003-4819-105-1-67","article-title":"Mitoxantrone: a new anticancer drug with significant clinical activity","volume":"105","author":"Shenkenberg","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bioorg.2021.105186_b0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2174\/1385272003375978","article-title":"Intercalative binding of small molecules to nucleic acids","volume":"4","author":"Graves","year":"2000","journal-title":"Curr. Org. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105186_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/meth.1998.0584","article-title":"Stacking interactions and intercalative DNA binding","volume":"14","author":"Gago","year":"1998","journal-title":"Methods"},{"key":"10.1016\/j.bioorg.2021.105186_b0130","series-title":"DNA Intercalators and topoisomerase inhibitors, Medicinal Chemistry of Anticancer Drugs","first-page":"199","author":"Avendano","year":"2008"},{"key":"10.1016\/j.bioorg.2021.105186_b0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2021.105186_b0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1023\/A:1008018106064","article-title":"Structure\u2013affinity relationships for the binding of actinomycin D to DNA","volume":"11","author":"Gallego","year":"1997","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2021.105186_b0145","doi-asserted-by":"crossref","first-page":"11493","DOI":"10.1021\/bi00204a011","article-title":"Binding of actinomycin D to the T (G) nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites","volume":"33","author":"Bailey","year":"1994","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.bioorg.2021.105186_b0150","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.fct.2009.04.043","article-title":"Chemical composition, antibacterial and antioxidant activities of leaf essential oil and extracts of Metasequioa glyptostroboides Miki ex Hu","volume":"47","author":"Bajpai","year":"2009","journal-title":"Food Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105186_b0155","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.50.2.556-564.2006","article-title":"3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria","volume":"50","author":"Yang","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105186_b0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijfoodmicro.2006.05.020","article-title":"Antibacterial activity of bioconverted eicosapentaenoic (EPA) and docosahexaenoic acid (DHA) against foodborne pathogenic bacteria","volume":"113","author":"Shin","year":"2007","journal-title":"Int. J. Food Microbiol."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2021.105186_b0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"17","key":"10.1016\/j.bioorg.2021.105186_b0170","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2021.105186_b0175","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/AEM.65.8.3727-3729.1999","article-title":"The MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] Assay Is a Fast and Reliable Method for Colorimetric Determination of Fungal Cell Densities","volume":"65","author":"Freimoser","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bioorg.2021.105186_b0180","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2017.06.004","article-title":"Cytotoxic effect of a novel naphthylchalcone against multiple cancer cells focusing on hematologic malignancies","volume":"140","author":"Maioral","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2021.105186_b0185","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/np50089a004","article-title":"A colorimetric microassay for the detection of agents that interact with DNA","volume":"55","author":"Burres","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bioorg.2021.105186_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104399","article-title":"Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors","volume":"105","author":"El-Adl","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"6041","key":"10.1016\/j.bioorg.2021.105186_b0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1126\/science.1204117","article-title":"Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide","volume":"333","author":"Wu","year":"2011","journal-title":"Science"},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2021.105186_b0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105186_b0205","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem.."},{"issue":"10","key":"10.1016\/j.bioorg.2021.105186_b0210","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/10ae05dc-90cb-46f1-aa2b-e63eb4a132e2","article-title":"Dahan, Oral Delivery of Lipophilic Drugs: The Tradeoff between Solubility Increase and Permeability Decrease When Using Cyclodextrin-Based Formulation","volume":"8","author":"Beig","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bioorg.2021.105186_b0215","unstructured":"G. Lewy and A. McAllan, Colorimetric methods for free and acetylated hexosamines: In Methods in Enzymology. vol.III, Academic Press Inc., New York. USA, 1959, pp. 58-66."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821005630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821005630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:25:49Z","timestamp":1778660749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821005630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":43,"alternative-id":["S0045206821005630"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105186","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105186"}}